Found: 2
Select item for more details and to access through your institution.
ASO Visual Abstract: Docetaxel, Cisplatin, and 5-FU Triplet Therapy as Conversion Therapy for Locoregionally Advanced Unresectable Esophageal Squamous Cell Carcinoma.
- Published in:
- 2023
- By:
- Publication type:
- Abstract
Docetaxel, Cisplatin, and 5-FU Triplet Therapy as Conversion Therapy for Locoregionally Advanced Unresectable Esophageal Squamous Cell Carcinoma.
- Published in:
- Annals of Surgical Oncology: An Oncology Journal for Surgeons, 2023, v. 30, n. 2, p. 861, doi. 10.1245/s10434-022-12694-8
- By:
- Publication type:
- Article